Music-sharing website Napster shuts down after a barrage of legal problems.
This reporter found out while trying to access Napster for…journalistic purposes, and now he has to step out for a few minutes to buy a CD.
Every time you buy a position, ask yourself:
If this position drops 50% at any point, will I add to my position?
If the answer is no, then you don’t have a long-term position.
I know everyone was making fun of $snap AR glasses design, but watching all the young people on love Island and even a lady talking on Bloomberg right now, they all have these gigantically framed glasses on. And their glasses don't even have a computer in them LOL
🚨 BREAKING: $HIMS SETS UP NEW $400 MILLION RECEIVABLES DEAL WITH J.P. MORGAN
Essentially, $HIMS can get cash upfront by selling JPM some unpaid bills owed to its XeCare and Apostrophe Pharmacy subsidiaries
Note: this is NOT a $400M raise today
It's a cash-flow tool with a $400M cap
JPM can choose which unpaid bills it wants to buy, and $HIMS gets cash sooner instead of waiting to collect later
$nke pretty happy with my $37.78 fill last night
i hold a core "forever" nike position in the portfolio
50 yo giant w/$6b cash and global fame. trade its death-rebirth cycle around core ✌️
Buy and hold works when you’ve already made your money
Buy, Trim, Rotate, Buy when you want to exponentially grow returns.
You need to compound your gains from high risk to low risk.
its very possible that in the future the models will be commercially "worthless" (lots of routes to this, nationalization for one).
means the lt winners ARE power/computer/software 🏆
$META has Excess Compute
$SPCX has Excess Compute
$GOOG, Anthropic & OpenAI do not…
Are we just seeing the “losers” in the race become backroom staff?
🚨 VALUATION GROUND FAULT
$DLR just paid $27M/MW at a 6.5% cap for three fully-leased AI data centers, with 3.6% escalators, 15-year leases. This is now the North Star for stabilized AI infra.
To refresh: Miners are converting Bitcoin infrastructure at $3-12M/MW. Same NOI economics (~$1.5M/MW). That's $15-24M/MW of value creation, if you can execute.
CIFR, and HUT are two public miners that have signed triple-net leases with investment-grade hyperscalers, the same lease structure as DLR's Northern Virginia portfolio.
To see what the market thinks of their remaining opportunity, take each company's disclosed stabilized NOI (net operating income), capitalize at DLR's 6.5% rate, and subtract net debt. That's the contracted book, valued at the clearing rate $DLR just paid. (The signed leases are already funded at the project level, so no additional equity is assumed to get there.)
Subtract that from the actual market cap. The residual is what you pay for everything uncontracted: the energized capacity sitting idle (or mining BTC) and the pipeline behind it.
The highest quality part of that residual is energized but unleased MW. Power on, interconnect done, substation built, no lease yet. Even if you attribute the entire residual to just these MW and give the pipeline zero credit, the implied values are roughly:
>$2.9M/MW for CIFR's ~313 MW >$2.1M/MW for HUT's ~443 MW.
Eight to fourteen cents on DLR's dollar for capacity that just needs a lease (not a permit).
And the gigawatts of development pipeline sitting behind all of that: Zero. The land is free.
There is no optimism in these valuations. In a market where plenty of stocks are priced off 2030 earnings, these companies cannot get any credit for powered land they already own.
The market is pricing the long-dated pipeline as if AI infrastructure demand stalls, lease rates collapse, and the opportunity never materializes.
Every lease signed, every MW energized, every quarter GPU rates hold is a step toward closing that gap.
I love that FDA/HHS stacked the panel with pro-peptide people... very good chance we see all 7 peptides moved to Category 1 which is good for $HIMS and anyone else selling non-GLP peptides that has access to and/or owns US based compounding pharmacies because FDA/HHS wants to crush the grey market and rightly so.
The FDA is scheduled to meet on the 23-24th of July to rule on peptides
The consensus is that a number of popular peptides will be approved
Their popularity has been explosive, the FDA will likely recommend that the market for peptides should meet strict standards and be controlled…instead of rogue peptides from the black market
One company benefits from this ruling: $HIMS
And right now the peptides total addressable market has not been built into its share price.
A strong move is expected.